Abstract
Objective
To analyze the effectiveness of Chinese medicine and integrated Chinese and Western medicine for influenza A (H1N1) in the fever clinics and its relevant expenditure.
Methods
A prospective survey on the clinical epidemic observation and follow-up was conducted from July 2009 to October 2009 with a self-developed questionnaire whose contents including the clinical data of the confirmed 149 H1N1 cases and their relevant therapeutic expenditure. The patients were assigned to the Chinese medicine group (22 cases treated by Chinese medicine alone) and integrative medicine group (124 cases treated by both Chinese medicine and Western medicine). The data were processed with descriptive analysis, t test and χ 2, and sum-rank test.
Results
The proportion of clinical recovery of Chinese medicine group (81.8%) was higher than that of integrative medicine group (54.8%) with statistical significance (P=0.02). The average fever durations in both groups were 3.5 to 4 days, showing no significant difference (P=0.86). In the comparisons of average cost of Chinese herbs, drugs, therapies, and total cost, those of the Chinese medicine group were lower than those in the integrative group (P=0.01, P=0.00, P=0.00, P=0.00).
Conclusions
The H1N1 patients in the fever clinic who received Chinese medicine treatment had a higher clinical recovery proportion than those who received integrated Chinese and Western medicine treatment with lower medical cost. However, due to small sample size of the Chinese medicine group in the study, the conclusion needs further confirmation by studies with large sample size.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ministry of Health, P. R. China. Notice for the hospitalization discharge criteria (Trial). http://www.Moh.gov.cn.
Zheng XY, ed. Guiding principle of clinical research on new drugs of traditional Chinese medicine. Beijing: China Medical Science and Technology Press; 2002:58–60.
Yan Y. To treat a severe case of influenza A costs 70 to 80 thousand RMB yuan. Health News; Dec 8, 2009.
Novel Swine—Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605–2615.
Uyeki T. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). N Engl J Med 2009;361:e110.
Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Emergence of oseltamivir—resistant pandemic H1N1 virus during prophylaxis. N Engl J Med 2009;361:2296–2297.
Wang YG, Wang XJ, Du HB, Zhang W, Wang RB, Li XW, et al. Report of 6 cases of confirmed H1N1 influenza A treated by integrated Chinese and Western medicine. Beijing J Tradit Chin Med (Chin) 2009;28:403–406.
Editorial Board of China Modern Medicine. Two cases of influenza A were controlled with Chinese herbal medicine in Guangdong province. China Modern Med (Chin) 2009;16(12):17.
Liu GX, Zhang YX, Yang JQ, Gao ZQ, Meng YC, et al. The randomized controlled study of Lianhua Qingwen Capsule in treating A/H1N1 iInfluenza. Chin J Diffic Complic Cas (Chin) 2010;9:14–16.
Zhang C. Chinese medicine is effective for influenza A. China News of Traditional Chinese Medicine; Aug 18, 2010.
Matheny J, Toner E, Waldhorn R. Financial effects of an influenza pandemic on US hospitals. J Health Care Finance 2007;34:58–63.
Nap RE, Andriessen MP, Meessen NE, van der Werf TS. Pandemic influenza and hospital resources. Emerg Infect Dis 2007;13:1714–1719.
Cinti S, Chenoweth C, Monto AS. Preparing for pandemic influenza: should hospitals stockpile oseltamivir? Infect Control Hosp Epidemiol 2005;26:852–854.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the H1N1 Influenza of the Clinical Study of Traditional Chinese Medicine Management Project by State Administration of Traditional Chinese Medicine (No. 200907001-2B)
Rights and permissions
About this article
Cite this article
Lu, Cj., Luo, Y., Zhou, H. et al. A preliminary study on the medical expenditure of Chinese medicine and integrative medicine treatment for influenza a (H1N1) in the fever clinics. Chin. J. Integr. Med. 16, 493–497 (2010). https://doi.org/10.1007/s11655-010-0563-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-010-0563-4